<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36830913</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">377</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11020377</ELocationID><Abstract><AbstractText>With a growing number of patients entering the recovery phase following infection with SARS-CoV-2, understanding the long-term neurological consequences of the disease is important to their care. The neurological complications of post-acute sequelae of SARS-CoV-2 infection (NC-PASC) represent a myriad of symptoms including headaches, brain fog, numbness/tingling, and other neurological symptoms that many people report long after their acute infection has resolved. Emerging reports are being published concerning COVID-19 and its chronic effects, yet limited knowledge of disease mechanisms has challenged therapeutic efforts. To address these issues, we review broadly the literature spanning 2020-2022 concerning the proposed mechanisms underlying NC-PASC, outline the long-term neurological sequelae associated with COVID-19, and discuss potential clinical interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Ian Z</ForeName><Initials>IZ</Initials><Identifier Source="ORCID">0000-0002-9032-9154</Identifier><AffiliationInfo><Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolson</LastName><ForeName>Dennis L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0002-7596-5726</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Matthew K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0003-0157-5669</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neurology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36830913</ArticleId><ArticleId IdType="pmc">PMC9953707</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11020377</ArticleId><ArticleId IdType="pii">biomedicines11020377</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. 2023.  [(accessed on 23 January 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2019;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Rojas M., Salinas M.L., Rodr&#xed;guez Y., Roa G., Lozano M., Rodr&#xed;guez-Jim&#xe9;nez M., Montoya N., Zapata E., Post-COVID Study Group et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 2021;20:102947. doi: 10.1016/j.autrev.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., Chung K.F. Confronting COVID-19-associated cough and the post-COVID syndrome: Role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir. Med. 2021;9:533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19): Post COVID-19 Condition. 2023.  [(accessed on 25 January 2023)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A., Mohamed M.S., Moulin T.C., Schi&#xf6;th H.B. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J. Neuroimmunol. 2021;358:577658. doi: 10.1016/j.jneuroim.2021.577658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577658</ArticleId><ArticleId IdType="pmc">PMC8272134</ArticleId><ArticleId IdType="pubmed">34304141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Ren Y., Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav. Immun. 2020;88:945&#x2013;946. doi: 10.1016/j.bbi.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7146652</ArticleId><ArticleId IdType="pubmed">32283294</ArticleId></ArticleIdList></Reference><Reference><Citation>McAbee G.N., Brosgol Y., Pavlakis S., Agha R., Gaffoor M. Encephalitis Associated with COVID-19 Infection in an 11-Year-Old Child. Pediatr. Neurol. 2020;109:94. doi: 10.1016/j.pediatrneurol.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7180343</ArticleId><ArticleId IdType="pubmed">32586676</ArticleId></ArticleIdList></Reference><Reference><Citation>Naz S., Hanif M., Haider M.A., Ali M.J., Ahmed M.U., Saleem S. Meningitis as an Initial Presentation of COVID-19: A Case Report. Front. Public Health. 2020;8:474. doi: 10.3389/fpubh.2020.00474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00474</ArticleId><ArticleId IdType="pmc">PMC7536294</ArticleId><ArticleId IdType="pubmed">33072684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi K., Poorbarat S., Abasi Z., Rahimi S., Khakshour A. Viral Meningitis Associated With COVID-19 in a 9-year-old Child: A Case Report. Pediatr. Infect. Dis. J. 2021;40:e87. doi: 10.1097/INF.0000000000002979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002979</ArticleId><ArticleId IdType="pubmed">33181787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati N., Kapila S., Bhalla Sehgal L., Sehgal V., Lnu P. Myelitis Following COVID-19 Illness. Cureus. 2022;14:e28134. doi: 10.7759/cureus.28134.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.28134</ArticleId><ArticleId IdType="pmc">PMC9482381</ArticleId><ArticleId IdType="pubmed">36134097</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z. Demyelination as a result of an immune response in patients with COVID-19. Acta Neurol. Belg. 2021;121:859&#x2013;866. doi: 10.1007/s13760-021-01691-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01691-5</ArticleId><ArticleId IdType="pmc">PMC8088756</ArticleId><ArticleId IdType="pubmed">33934300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikbakht F., Mohammadkhanizadeh A., Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult. Scler. Relat. Disord. 2020;46:102535. doi: 10.1016/j.msard.2020.102535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102535</ArticleId><ArticleId IdType="pmc">PMC7521932</ArticleId><ArticleId IdType="pubmed">33010584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kincaid K.J., Kung J.C., Senetar A.J., Mendoza D., Bonnin D.A., Purtlebaugh W.L., Cabatbat R.M., Dickens R., Echevarria F.D., Kariyawasam V., et al. Post-COVID seizure: A new feature of &#x201c;long-COVID&#x201d;. eNeurologicalSci. 2021;23:100340. doi: 10.1016/j.ensci.2021.100340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2021.100340</ArticleId><ArticleId IdType="pmc">PMC8053221</ArticleId><ArticleId IdType="pubmed">33898792</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay S., Basu S., Majumdar K. Seizure after recovery from Covid-19. J. Fam. Med. Prim. Care. 2021;10:2713. doi: 10.4103/jfmpc.jfmpc_2478_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_2478_20</ArticleId><ArticleId IdType="pmc">PMC8415682</ArticleId><ArticleId IdType="pubmed">34568161</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a C.C., S&#xe1;nchez E.A., Huerta D.H., G&#xf3;mez-Arnau J. Covid-19 treatment-induced neuropsychiatric adverse effects. Gen. Hosp. Psychiatry. 2020;67:163&#x2013;164. doi: 10.1016/j.genhosppsych.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7286227</ArticleId><ArticleId IdType="pubmed">32636036</ArticleId></ArticleIdList></Reference><Reference><Citation>Jewell P., Ansorge O., Kuker W., Irani S.R., Zamboni G. Tocilizumab-associated multifocal cerebral thrombotic microangiopathy. Neurol. Clin. Pract. 2016;6:e24&#x2013;e26. doi: 10.1212/CPJ.0000000000000220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000220</ArticleId><ArticleId IdType="pmc">PMC4909526</ArticleId><ArticleId IdType="pubmed">27347443</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E., Giussani G., Westenberg E., Allegri R., Garcia-Azorin D., Guekht A., Frontera J., Kivipelto M., Mangialasche F., Mukaetova-Ladinska E.B., et al. Acute and post-acute neurological manifestations of COVID-19: Present findings, critical appraisal, and future directions. J. Neurol. 2022;269:2265&#x2013;2274. doi: 10.1007/s00415-021-10848-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10848-4</ArticleId><ArticleId IdType="pmc">PMC8528941</ArticleId><ArticleId IdType="pubmed">34674005</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J. Med. Virol. 2021;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M.J., Barrientos R.M. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav. Immun. 2020;87:53&#x2013;54. doi: 10.1016/j.bbi.2020.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7165103</ArticleId><ArticleId IdType="pubmed">32311498</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2019;The long tail of Covid-19&#x2019; - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H., Alsrhani A., Zafar A., Javed H., Junaid K., Abdalla A.E., Abosalif K.O.A., Ahmed Z., Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health. 2020;13:1833&#x2013;1839. doi: 10.1016/j.jiph.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalleballe K., Siddamreddy S., Sheng S., Dandu V., Arulprakash N., Kovvuru S., Kamran M., Jasti M., Onteddu S. Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke. Cureus. 2020;12:e10231. doi: 10.7759/cureus.10231.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10231</ArticleId><ArticleId IdType="pmc">PMC7535872</ArticleId><ArticleId IdType="pubmed">33042672</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow I., Lee K.S., Zhang J.J.Y., Saffari S.E., Ng A., Young B. Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors. J. Stroke Cerebrovasc. Dis. 2021;30:105549. doi: 10.1016/j.jstrokecerebrovasdis.2020.105549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105549</ArticleId><ArticleId IdType="pmc">PMC7834121</ArticleId><ArticleId IdType="pubmed">33341565</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., Ueno M., Sakata H., Kondo K., Myose N., et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., Normandin E., Bhattacharyya S., Mukerji S.S., Keller K., Ali A.S., Adams G., Hornick J.L., Padera R.F., Jr., Sabeti P. Neuropathological Features of Covid-19. N. Engl. J. Med. 2020;383:989&#x2013;992. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid C., Brady M., Deane R. SARS-CoV-2: Is there neuroinvasion? Fluids Barriers CNS. 2021;18:32. doi: 10.1186/s12987-021-00267-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-021-00267-y</ArticleId><ArticleId IdType="pmc">PMC8278192</ArticleId><ArticleId IdType="pubmed">34261487</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcez P.P., Loiola E.C., Madeiro da Costa R., Higa L.M., Trindade P., Delvecchio R., Nascimento J.M., Brindeiro R., Tanuri A., Rehen S.K. Zika virus impairs growth in human neurospheres and brain organoids. Science. 2016;352:816&#x2013;818. doi: 10.1126/science.aaf6116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6116</ArticleId><ArticleId IdType="pubmed">27064148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L.Y., Komarasamy T.V., James W., Balasubramaniam V.R.M.T. Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy. Front. Microbiol. 2022;13:743147. doi: 10.3389/fmicb.2022.743147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.743147</ArticleId><ArticleId IdType="pmc">PMC8931420</ArticleId><ArticleId IdType="pubmed">35308394</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner I., Kennedy P.G., Pachner A.R. The neurotropic herpes viruses: Herpes simplex and varicella-zoster. Lancet Neurol. 2007;6:1015&#x2013;1028. doi: 10.1016/S1474-4422(07)70267-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70267-3</ArticleId><ArticleId IdType="pubmed">17945155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cl&#xe9; M., Eldin P., Briant L., Lannuzel A., Simonin Y., Van de Perre P., Cabi&#xe9; A., Salinas S. Neurocognitive impacts of arbovirus infections. J. Neuroinflammation. 2020;17:233. doi: 10.1186/s12974-020-01904-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01904-3</ArticleId><ArticleId IdType="pmc">PMC7418199</ArticleId><ArticleId IdType="pubmed">32778106</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.C., Zhang Y., Tan B.H. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2. J. Med. Virol. 2021;93:4247&#x2013;4257. doi: 10.1002/jmv.26943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26943</ArticleId><ArticleId IdType="pmc">PMC8250680</ArticleId><ArticleId IdType="pubmed">33724490</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukerji S.S., Solomon I.H. What can we learn from brain autopsies in COVID-19? Neurosci. Lett. 2021;742:135528. doi: 10.1016/j.neulet.2020.135528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135528</ArticleId><ArticleId IdType="pmc">PMC7687409</ArticleId><ArticleId IdType="pubmed">33248159</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar M.A., Shakkour Z., Reslan M.A., Al-Haj N., Chamoun P., Habashy K., Kaafarani H., Shahjouei S., Farran S.H., Shaito A., et al. SARS-CoV-2 involvement in central nervous system tissue damage. Neural Regen. Res. 2022;17:1228&#x2013;1239. doi: 10.4103/1673-5374.327323.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.327323</ArticleId><ArticleId IdType="pmc">PMC8643043</ArticleId><ArticleId IdType="pubmed">34782556</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilinska K. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. ACS Chem. Neurosci. 2020;11:1200&#x2013;1203. doi: 10.1021/acschemneuro.0c00172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00172</ArticleId><ArticleId IdType="pubmed">32283006</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Yoo S.J., Clijsters M., Backaert W., Vanstapel A., Speleman K., Lietaer C., Choi S., Hether T.D., Marcelis L., et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932&#x2013;5949.e15. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M.A., Rhea E.M., Knopp R.C., Banks W.A. Interactions of SARS-CoV-2 with the Blood&#x2013;Brain Barrier. Int. J. Mol. Sci. 2021;22:2681. doi: 10.3390/ijms22052681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J., Mahzabin S., M&#xe4;yr&#xe4;np&#xe4;&#xe4; M.I., Tynninen O., Paetau A., Andersson N., Sajantila A., Vapalahti O., Carp&#xe9;n O., Kek&#xe4;l&#xe4;inen E., et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30:1012&#x2013;1016. doi: 10.1111/bpa.12889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12889</ArticleId><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Khot S., Tirschwell D.L. Long-term neurological complications after hypoxic-ischemic encephalopathy. Semin. Neurol. 2006;26:422&#x2013;431. doi: 10.1055/s-2006-948323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2006-948323</ArticleId><ArticleId IdType="pubmed">16969743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasannejad C., Ely E.W., Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: A review of clinical impact and pathophysiological mechanisms. Crit. Care. 2019;23:352. doi: 10.1186/s13054-019-2626-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2626-z</ArticleId><ArticleId IdType="pmc">PMC6852966</ArticleId><ArticleId IdType="pubmed">31718695</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondaine T., Ruthmann F., Vuotto F., Carton L., Gel&#xe9; P., Faure K., Deplanque D., Bordet R. Long-term cognitive impairments following COVID-19: A possible impact of hypoxia. J. Neurol. 2022;269:3982&#x2013;3989. doi: 10.1007/s00415-022-11077-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11077-z</ArticleId><ArticleId IdType="pmc">PMC8944178</ArticleId><ArticleId IdType="pubmed">35325308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A., Tabassum T., Araf Y., Al Nahid A., Ullah M.A., Hosen M.J. Silent hypoxia in COVID-19: Pathomechanism and possible management strategy. Mol. Biol. Rep. 2021;48:3863&#x2013;3869. doi: 10.1007/s11033-021-06358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06358-1</ArticleId><ArticleId IdType="pmc">PMC8062941</ArticleId><ArticleId IdType="pubmed">33891272</ArticleId></ArticleIdList></Reference><Reference><Citation>Fries M., Bickenbach J., Henzler D., Beckers S., Dembinski R., Sellhaus B., Rossaint R., Kuhlen R. S-100 Protein and Neurohistopathologic Changes in a Porcine Model of Acute Lung Injury. Anesthesiology. 2005;102:761&#x2013;767. doi: 10.1097/00000542-200504000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200504000-00011</ArticleId><ArticleId IdType="pubmed">15791105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickenbach J., Biener I., Czaplik M., Nolte K., Dembinski R., Marx G., Rossaint R., Fries M. Neurological outcome after experimental lung injury. Respir. Physiol. Neurobiol. 2011;179:174&#x2013;180. doi: 10.1016/j.resp.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2011.08.003</ArticleId><ArticleId IdType="pubmed">21855657</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., Patel P., Medicherla C., Arena V., Fang T., Andino A., Snyder T., Madhavan M., et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426:117486. doi: 10.1016/j.jns.2021.117486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Wang H., Lv J., Pei H., Bai Z. Predictors of Mortality in Hospitalized COVID-19 Patients Complicated With Hypotension and Hypoxemia: A Retrospective Cohort Study. Front. Med. 2021;8:753035. doi: 10.3389/fmed.2021.753035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.753035</ArticleId><ArticleId IdType="pmc">PMC8581201</ArticleId><ArticleId IdType="pubmed">34778315</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocchetti N., Furlan A., Volta F. Hypoxemia and Arterial Hypotension at the Accident Scene in Head Injury. J. Trauma Acute Care Surg. 1996;40:764&#x2013;767. doi: 10.1097/00005373-199605000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199605000-00014</ArticleId><ArticleId IdType="pubmed">8614077</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Ptacek R., Ptackova H., Martin A., Kream R.M. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce &#x2018;Brain Fog&#x2019; and Results in Behavioral Changes that Favor Viral Survival. Med Sci. Monit. Int. Med J. Exp. Clin. Res. 2021;27:e930886-1&#x2013;e930886-4. doi: 10.12659/MSM.930886.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930886</ArticleId><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C., Liu Z., Zhu Y., Lu J., Ge C., Zhang C., Li N., Jin N., Li Y., Tian M., et al. SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment. Front. Microbiol. 2022;12:4159. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Ramirez S., Greenberg S.M., Viswanathan A. Cerebral microbleeds: Overview and implications in cognitive impairment. Alzheimer&#x2019;s Res. Ther. 2014;6:33. doi: 10.1186/alzrt263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt263</ArticleId><ArticleId IdType="pmc">PMC4075149</ArticleId><ArticleId IdType="pubmed">24987468</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Jain R., Dogra S., Krieger P., Lewis A., Nguyen V., Melmed K., Galetta S. Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19. Stroke. 2020;51:2649&#x2013;2655. doi: 10.1161/STROKEAHA.120.030940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030940</ArticleId><ArticleId IdType="pmc">PMC7434006</ArticleId><ArticleId IdType="pubmed">32755456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez Elizondo E.F., Valdez Ram&#xed;rez J.A., Barraza Aguirre G., Dautt Medina P.M., Berlanga Estens J. Central Nervous System Injury in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: MRI Findings. Cureus. 2021;13:e18052. doi: 10.7759/cureus.18052.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18052</ArticleId><ArticleId IdType="pmc">PMC8523342</ArticleId><ArticleId IdType="pubmed">34692282</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitsiori A., Pugin D., Thieffry C., Lalive P., Vargas M.I. COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients. J. Neuroimaging. 2020;30:593&#x2013;597. doi: 10.1111/jon.12755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12755</ArticleId><ArticleId IdType="pmc">PMC7361874</ArticleId><ArticleId IdType="pubmed">32639679</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T., Lolli V., Sadeghi N., Rovai A., Trotta N., Taccone F.S., Creteur J., Henrard S., Goffard J.C., Dewitte O., et al. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020;95:e2016&#x2013;e2027. doi: 10.1212/WNL.0000000000010116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010116</ArticleId><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D., Imbach L.L., Rushing E.J., Frauenknecht K.B.M., Gascho D., Ineichen B.V., Keller E., Kohler S., Lichtblau M., Reimann R.R., et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol. Appl. Neurobiol. 2021;47:454&#x2013;459. doi: 10.1111/nan.12677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12677</ArticleId><ArticleId IdType="pmc">PMC7753688</ArticleId><ArticleId IdType="pubmed">33249605</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon L., McNamara C., Gaur P., Mallon D., Coughlan C., Tona F., Jan W., Wilson M., Jones B. Cerebral microhaemorrhage in COVID-19: A critical illness related phenomenon? Stroke Vasc. Neurol. 2020;5:315&#x2013;322. doi: 10.1136/svn-2020-000652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000652</ArticleId><ArticleId IdType="pmc">PMC7681795</ArticleId><ArticleId IdType="pubmed">33208493</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghayari Sheikh Neshin S., Shahjouei S., Koza E., Friedenberg I., Khodadadi F., Sabra M., Kobeissy F., Ansari S., Tsivgoulis G., Li J., et al. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front. Cardiovasc. Med. 2021;8:649922. doi: 10.3389/fcvm.2021.649922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.649922</ArticleId><ArticleId IdType="pmc">PMC8039152</ArticleId><ArticleId IdType="pubmed">33855053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Kodavati M., Provasek V.E., Rao K.S., Mitra S., Hamilton D.J., Horner P.J., Vahidy F.S., Britz G.W., Kent T.A., et al. SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations. Ageing Res. Rev. 2022;80:101687. doi: 10.1016/j.arr.2022.101687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101687</ArticleId><ArticleId IdType="pmc">PMC9288264</ArticleId><ArticleId IdType="pubmed">35843590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020;11:1446. doi: 10.3389/fimmu.2020.01446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ari&#xf1;o H., Heartshorne R., Michael B.D., Nicholson T.R., Vincent A., Pollak T.A., Vogrig A. Neuroimmune disorders in COVID-19. J. Neurol. 2022;269:2827&#x2013;2839. doi: 10.1007/s00415-022-11050-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11050-w</ArticleId><ArticleId IdType="pmc">PMC9120100</ArticleId><ArticleId IdType="pubmed">35353232</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira C., Crespo &#xc2;., Ranjbar S., de Lacerda L.B., Lewandrowski M., Ingber J., Parry B., Ravid S., Clark S., Schrimpf M.R., et al. Fc&#x3b3;R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022;606:576&#x2013;584. doi: 10.1038/s41586-022-04702-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04702-4</ArticleId><ArticleId IdType="pmc">PMC10071495</ArticleId><ArticleId IdType="pubmed">35385861</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Gutierrez S., Tobalina M., Diaz-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquisiras-Burgos I., Peralta-Arrieta I., Alonso-Palomares L.A., Zacapala-G&#xf3;mez A.E., Salmer&#xf3;n-B&#xe1;rcenas E.G., Aguilera P. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection. Mol. Neurobiol. 2021;58:520&#x2013;535. doi: 10.1007/s12035-020-02134-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02134-7</ArticleId><ArticleId IdType="pmc">PMC7518400</ArticleId><ArticleId IdType="pubmed">32978729</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., Mehrabadi M.A., Abrihim H., Dutt N., Lambert N., Nurmi E.L., Chakraborty R., Rahmani A.M., et al. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv. 2021 doi: 10.1101/2021.03.03.21252086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L., Wang Q., Zhang D., Ding J., Huang Q., Tang Y.Q., Wang Q., Miao H. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study. Signal Transduct. Target. Ther. 2020;5:1&#x2013;3. doi: 10.1038/s41392-020-0148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0148-4</ArticleId><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., Cheruiyot I., Vikse J., Mutua V., Kipkorir V., Benoit J., Plebani M., Bragazzi N., Lippi G. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: A meta-analysis. Acta Bio Medica Atenei Parm. 2020;91:e2020008. doi: 10.23750/abm.v91i3.10217.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i3.10217</ArticleId><ArticleId IdType="pmc">PMC7716963</ArticleId><ArticleId IdType="pubmed">32921706</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Long W., Tu M., Chen S., Huang Y., Wang S., Zhou W., Chen D., Zhou L., Wang M., et al. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J. Infect. 2020;81:318&#x2013;356. doi: 10.1016/j.jinf.2020.03.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.054</ArticleId><ArticleId IdType="pmc">PMC7151318</ArticleId><ArticleId IdType="pubmed">32283159</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y., Luo L., Chen Y., Westerberg L.S., Zhou P., Xu Z., Herrada A.A., Park C.S., Kubo M., Mei H., et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct. Target. Ther. 2021;6:345. doi: 10.1038/s41392-021-00749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00749-3</ArticleId><ArticleId IdType="pmc">PMC8456405</ArticleId><ArticleId IdType="pubmed">34552055</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavoshzadeh Z., Hashemitari A., Darougar S. Neurological Manifestations of Primary Immunodeficiencies. Iran. J. Child Neurol. 2018;12:7&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6045935</ArticleId><ArticleId IdType="pubmed">30026765</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat. Rev. Rheumatol. 2020;16:413&#x2013;414. doi: 10.1038/s41584-020-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sawalha A.H., Lu Q. COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 2021;33:155&#x2013;162. doi: 10.1097/BOR.0000000000000776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Bartley C.M., Chow R.D., Ngo T.T., Jiang R., Zamecnik C.R., Dandekar R., Loudermilk R.P., Dai Y., Liu F., et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep. Med. 2021;2:100288. doi: 10.1016/j.xcrm.2021.100288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100288</ArticleId><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N., Rezaei N. Autoimmune complications of COVID-19. J. Med. Virol. 2022;94:54&#x2013;62. doi: 10.1002/jmv.27292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27292</ArticleId><ArticleId IdType="pmc">PMC8661629</ArticleId><ArticleId IdType="pubmed">34427929</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan P.O., Behan W.M.H., Bell E.J. The postviral fatigue syndrome &#x2014;An analysis of the findings in 50 cases. J. Infect. 1985;10:211&#x2013;222. doi: 10.1016/S0163-4453(85)92488-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-4453(85)92488-0</ArticleId><ArticleId IdType="pubmed">2993423</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowsett E.G., Ramsay A.M., McCartney R.A., Bell E.J. Myalgic encephalomyelitis&#x2013;a persistent enteroviral infection? Postgrad. Med. J. 1990;66:526&#x2013;530. doi: 10.1136/pgmj.66.777.526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.66.777.526</ArticleId><ArticleId IdType="pmc">PMC2429637</ArticleId><ArticleId IdType="pubmed">2170962</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M., Mastronardi C., Silva-Aldana C.T., Arcos-Burgos M., Lidbury B.A. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics. 2019;9:91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020;77:1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Korteweg C. Pathology and Pathogenesis of Severe Acute Respiratory Syndrome. Am. J. Pathol. 2007;170:1136&#x2013;1147. doi: 10.2353/ajpath.2007.061088.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.061088</ArticleId><ArticleId IdType="pmc">PMC1829448</ArticleId><ArticleId IdType="pubmed">17392154</ArticleId></ArticleIdList></Reference><Reference><Citation>Patcai J. Is &#x2018;Long Covid&#x2019; similar to &#x2018;Long SARS&#x2019;? Oxf. Open Immunol. 2022;3:iqac002. doi: 10.1093/oxfimm/iqac002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqac002</ArticleId><ArticleId IdType="pmc">PMC9914492</ArticleId><ArticleId IdType="pubmed">36846562</ArticleId></ArticleIdList></Reference><Reference><Citation>Stainsby B., Howitt S., Porr J. Neuromusculoskeletal disorders following SARS: A case series. J. Can. Chiropr. Assoc. 2011;55:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044805</ArticleId><ArticleId IdType="pubmed">21403780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C.C., Tsai L.K., Chiou Y.H., Tseng M.T., Hsieh S.T., Chang S.C., Chang Y.C. Peripheral nerve disease in SARS:: Report of a case. Neurology. 2003;61:1820&#x2013;1821. doi: 10.1212/01.WNL.0000099171.26943.D0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000099171.26943.D0</ArticleId><ArticleId IdType="pubmed">14694063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li Y., Liu Q., Yao Q., Wang X., Zhang H., Chen R., Ren L., Min J., Deng F., et al. SARS-CoV-2 cell tropism and multiorgan infection. Cell Discov. 2021;7:1&#x2013;4. doi: 10.1038/s41421-021-00249-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00249-2</ArticleId><ArticleId IdType="pmc">PMC7987126</ArticleId><ArticleId IdType="pubmed">33758165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason R.J. Pathogenesis of COVID-19 from a cell biology perspective. Eur. Respir. J. 2020;55:2000607. doi: 10.1183/13993003.00607-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00607-2020</ArticleId><ArticleId IdType="pmc">PMC7144260</ArticleId><ArticleId IdType="pubmed">32269085</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley R., Kimberlin D.W., Prober C.G. Pathogenesis and disease. In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., Yamanishi K., editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge University Press; Cambridge, UK: 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">21348071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy P.G.E., Rovnak J., Badani H., Cohrs R.J. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J. Gen. Virol. 2015;96:1581&#x2013;1602. doi: 10.1099/vir.0.000128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000128</ArticleId><ArticleId IdType="pmc">PMC4635449</ArticleId><ArticleId IdType="pubmed">25794504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Zuo Y., Jiang L., Peng Y., Huang X., Zuo L. Epstein-Barr Virus and Neurological Diseases. Front. Mol. Biosci. 2022;8:816098. doi: 10.3389/fmolb.2021.816098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.816098</ArticleId><ArticleId IdType="pmc">PMC8784775</ArticleId><ArticleId IdType="pubmed">35083281</ArticleId></ArticleIdList></Reference><Reference><Citation>Domachowske J.B., Cunningham C.K., Cummings D.L., Crosley C.J., Hannan W.P., Weiner L.B. Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children. Pediatr. Infect. Dis. J. 1996;15:871. doi: 10.1097/00006454-199610000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199610000-00008</ArticleId><ArticleId IdType="pubmed">8895918</ArticleId></ArticleIdList></Reference><Reference><Citation>Tselis A.C. Chapter 13 - Epstein&#x2013;Barr virus infections of the nervous system. In: Tselis A.C., Booss J., editors. Handbook of Clinical Neurology. Volume 123. Elsevier; Amsterdam, The Netherlands: 2014. pp. 285&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-53488-0.00013-4</ArticleId><ArticleId IdType="pubmed">25015491</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;usler M., Ramaekers V.T., Doenges M., Schweizer K., Ritter K., Schaade L. Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients. J. Med. Virol. 2002;68:253&#x2013;263. doi: 10.1002/jmv.10201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10201</ArticleId><ArticleId IdType="pubmed">12210416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinzger C., Digel M., Jahn G. Cytomegalovirus Cell Tropism. In: Shenk T.E., Stinski M.F., editors. Human Cytomegalovirus. Springer; Berlin/Heidelberg, Germany: 2008. pp. 63&#x2013;83. Current Topics in Microbiology and Immunology.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-77349-8_4</ArticleId><ArticleId IdType="pubmed">18637500</ArticleId></ArticleIdList></Reference><Reference><Citation>Krstanovi&#x107; F., Britt W.J., Jonji&#x107; S., Brizi&#x107; I. Cytomegalovirus Infection and Inflammation in Developing Brain. Viruses. 2021;13:1078. doi: 10.3390/v13061078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061078</ArticleId><ArticleId IdType="pmc">PMC8227981</ArticleId><ArticleId IdType="pubmed">34200083</ArticleId></ArticleIdList></Reference><Reference><Citation>Turriziani Colonna A., Buonsenso D., Pata D., Salerno G., Chieffo D.P.R., Romeo D.M., Faccia V., Conti G., Molle F., Baldascino A., et al. Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir. Front. Med. 2020;7:268. doi: 10.3389/fmed.2020.00268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00268</ArticleId><ArticleId IdType="pmc">PMC7393008</ArticleId><ArticleId IdType="pubmed">32793607</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown H.L., Abernathy M.P. Cytomegalovirus infection. Semin. Perinatol. 1998;22:260&#x2013;266. doi: 10.1016/S0146-0005(98)80014-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0146-0005(98)80014-1</ArticleId><ArticleId IdType="pubmed">9738990</ArticleId></ArticleIdList></Reference><Reference><Citation>Laureti M., Narayanan D., Rodriguez-Andres J., Fazakerley J.K., Kedzierski L. Flavivirus Receptors: Diversity, Identity, and Cell Entry. Front. Immunol. 2018;9:2180. doi: 10.3389/fimmu.2018.02180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02180</ArticleId><ArticleId IdType="pmc">PMC6168832</ArticleId><ArticleId IdType="pubmed">30319635</ArticleId></ArticleIdList></Reference><Reference><Citation>Matusali G., Colavita F., Bordi L., Lalle E., Ippolito G., Capobianchi M.R., Castilletti C. Tropism of the Chikungunya Virus. Viruses. 2019;11:175. doi: 10.3390/v11020175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11020175</ArticleId><ArticleId IdType="pmc">PMC6410217</ArticleId><ArticleId IdType="pubmed">30791607</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz O., Albert M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 2010;8:491&#x2013;500. doi: 10.1038/nrmicro2368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2368</ArticleId><ArticleId IdType="pubmed">20551973</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ewijk R., Huibers M.H.W., Manshande M.E., Ecury-Goossen G.M., Duits A.J., Calis J.C., van Wassenaer-Leemhuis A.G. Neurologic sequelae of severe chikungunya infection in the first 6 months of life: A prospective cohort study 24-months post-infection. BMC Infect. Dis. 2021;21:179. doi: 10.1186/s12879-021-05876-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05876-4</ArticleId><ArticleId IdType="pmc">PMC7885242</ArticleId><ArticleId IdType="pubmed">33593326</ArticleId></ArticleIdList></Reference><Reference><Citation>McArthur J.C., Brew B.J., Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4:543&#x2013;555. doi: 10.1016/S1474-4422(05)70165-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70165-4</ArticleId><ArticleId IdType="pubmed">16109361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghorpade A., Nukuna A., Che M., Haggerty S., Persidsky Y., Carter E., Carhart L., Shafer L., Gendelman H.E. Human Immunodeficiency Virus Neurotropism: An Analysis of Viral Replication and Cytopathicity for Divergent Strains in Monocytes and Microglia. J. Virol. 1998;72:3340&#x2013;3350. doi: 10.1128/JVI.72.4.3340-3350.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.4.3340-3350.1998</ArticleId><ArticleId IdType="pmc">PMC109814</ArticleId><ArticleId IdType="pubmed">9525661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel M.A., Gilden D. Neurological Complications of VZV Reactivation. Curr. Opin. Neurol. 2014;27:356&#x2013;360. doi: 10.1097/WCO.0000000000000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000092</ArticleId><ArticleId IdType="pmc">PMC4189810</ArticleId><ArticleId IdType="pubmed">24792344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale N.S., McIntyre A.B.R., Mattocks M.D., Holley C.L., Lazear H.M., Mason C.E., Horner S.M. Altered m6A Modification of Specific Cellular Transcripts Affects Flaviviridae Infection. Mol. Cell. 2020;77:542&#x2013;555.e8. doi: 10.1016/j.molcel.2019.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.11.007</ArticleId><ArticleId IdType="pmc">PMC7007864</ArticleId><ArticleId IdType="pubmed">31810760</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo C.P., Barros-Arag&#xe3;o F.G.Q., Neris R.L.S., Frost P.S., Soares C., Souza I.N.O., Zeidler J.D., Zamberlan D.C., de Sousa V.L., Souza A.S., et al. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice. Nat. Commun. 2019;10:3890. doi: 10.1038/s41467-019-11866-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11866-7</ArticleId><ArticleId IdType="pmc">PMC6728367</ArticleId><ArticleId IdType="pubmed">31488835</ArticleId></ArticleIdList></Reference><Reference><Citation>Saylor D. Neurologic Complications of Human Immunodeficiency Virus Infection. Contin. (Minneap Minn) 2018;24:1397&#x2013;1421. doi: 10.1212/CON.0000000000000647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000647</ArticleId><ArticleId IdType="pmc">PMC8006925</ArticleId><ArticleId IdType="pubmed">30273245</ArticleId></ArticleIdList></Reference><Reference><Citation>McCutchan J.A. Cytomegalovirus Infections of the Nervous System in Patients with AIDS. Clin. Infect. Dis. 1995;20:747&#x2013;754. doi: 10.1093/clinids/20.4.747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.4.747</ArticleId><ArticleId IdType="pubmed">7795068</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.R. Epstein&#x2013;Barr Virus, the Immune System, and Associated Diseases. Front. Microbiol. 2011;2:5. doi: 10.3389/fmicb.2011.00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2011.00005</ArticleId><ArticleId IdType="pmc">PMC3109484</ArticleId><ArticleId IdType="pubmed">21687403</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Presti E., Nuzzo D., Al Mahmeed W., Al-Rasadi K., Al-Alawi K., Banach M., Banerjee Y., Ceriello A., Cesur M., Cosentino F., et al. Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health. Biochim. Et Biophys. Acta Mol. Basis Dis. 2022;1868:166559. doi: 10.1016/j.bbadis.2022.166559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166559</ArticleId><ArticleId IdType="pmc">PMC9510069</ArticleId><ArticleId IdType="pubmed">36174875</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. &#x201c;LONG COVID&#x201d;&#x2014;A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E., Hall K.H., Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis. Transl. Med. 2021;7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S., Catalogna M., Sasson E., Elman-Shina K., Hadanny A., Lang E., Finci S., Polak N., Fishlev G., Korin C., et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: Randomized controlled trial. Sci. Rep. 2022;12:11252. doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini J.J., Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020;323:2329&#x2013;2330. doi: 10.1001/jama.2020.6825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6825</ArticleId><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson O.J., Barnsley G., Toor J., Hogan A.B., Winskill P., Ghani A.C. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect. Dis. 2022;22:1293&#x2013;1302. doi: 10.1016/S1473-3099(22)00320-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00320-6</ArticleId><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards M.J., Becker K.A., Gripp B., Hoffmann M., Keitsch S., Wilker B., Soddemann M., Gulbins A., Carpinteiro E., Patel S.H., et al. Sphingosine prevents binding of SARS&#x2013;CoV-2 spike to its cellular receptor ACE2. J. Biol. Chem. 2020;295:15174&#x2013;15182. doi: 10.1074/jbc.RA120.015249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015249</ArticleId><ArticleId IdType="pmc">PMC7650243</ArticleId><ArticleId IdType="pubmed">32917722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan R., Kilaru A., Hemmer B., Cree B.A.C., Greenberg B.M., Kundu U., Hach T., DeLasHeras V., Ward B.J., Berger J. COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients: Case Series. Neurol. Neuroinflammation. 2022;9 doi: 10.1212/NXI.0000000000001092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001092</ArticleId><ArticleId IdType="pmc">PMC8860466</ArticleId><ArticleId IdType="pubmed">34848501</ArticleId></ArticleIdList></Reference><Reference><Citation>Meacci E., Garcia-Gil M., Pierucci F. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Int. J. Mol. Sci. 2020;21:6773. doi: 10.3390/ijms21186773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21186773</ArticleId><ArticleId IdType="pmc">PMC7556035</ArticleId><ArticleId IdType="pubmed">32942748</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachy B. Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-Year Follow-up of &#x201c;Long COVID-19&#x201d; Patients. Clinical trial registration NCT05492292, clinicaltrials.gov.  [(accessed on 15 December 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05492292.</Citation></Reference><Reference><Citation>Medical University Innsbruck  Long-term Neurological Outcome After SARS-CoV-2 Infection. Clinical trial registration NCT05025839, clinicaltrials.gov.  [(accessed on 15 December 2022)];2021  Available online:  https://clinicaltrials.gov/ct2/show/NCT05025839.</Citation></Reference><Reference><Citation>GeNeuro S.A. Temelimab as a Disease Modifying Therapy in Patients With Neurological, Neuropsychological, and Psychiatric (=Neuropsychiatric) Symptoms in Post-COVID 19 or Postacute Sequelae of COVID-19 (PASC) Syndrome. Clinical trial registration NCT05497089, clinicaltrials.gov.  [(accessed on 15 December 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05497089.</Citation></Reference><Reference><Citation>National Institute of Neurological Disorders and Stroke (NINDS)  Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (IN-PASC). Clinical trial registration NCT05350774, clinicaltrials.gov.  [(accessed on 15 December 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05350774.</Citation></Reference><Reference><Citation>Najafi B. Transcutaneous Electrical Nerve Stimulation for Lower Extremity in Patients with Post Acute Covid-19 Syndrome&#x2014;A Proof of Concept Randomized Clinical Trial. Clinical Trial Registration NCT05200858, clinicaltrials.gov.  [(accessed on 15 December 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05200858.</Citation></Reference><Reference><Citation>Trapl-Grundschober M. Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia. Clinical Trial Registration NCT05190718, clinicaltrials.gov.  [(accessed on 15 December 2022)];2021  Available online:  https://clinicaltrials.gov/ct2/show/NCT05190718.</Citation></Reference><Reference><Citation>Zheng A. Multimodal Investigation of Post COVID-19 in Females: A Pilot Study. Clinical trial registration NCT05225220, clinicaltrials.gov.  [(accessed on 15 December 2022)];2022  Available online:  https://clinicaltrials.gov/ct2/show/NCT05225220.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>